Reporting of Suspected Adverse Drug Reactions for Human Use: Pharmacovigilance

Contact Us

I have read and agreed to the

At Pharmaceutical Innovation Services S.L., we are committed to ensuring the safety of the medicines we commercialize. As the holder of the marketing authorization for medicines, we are obligated to maintain a surveillance system that allows us to manage suspected adverse drug reactions (ADRs) for human use.

If you are aware of any suspected adverse drug reaction for human use related to one of our products, please report it using one of the following methods:

  1. Reporting form: Please fill out the form located on the left-hand side to submit any adverse reaction.
  2. Phone (24 hours): Call us at 644 13 55 02 / 655 30 63 03 to report any adverse event directly.
  3. Email: You can also send your report to pv@, and our pharmacovigilance team will handle your case.

Pharmacovigilance is the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. At Pharmaceutical Innovation Services S.L., we carry out monitoring and surveillance activities, which include reviewing and evaluating reports of suspected adverse reactions, epidemiological studies, published literature, and/or additional clinical trials.

Our goal is to guarantee the highest level of safety for the products we distribute. Therefore, it is essential that any potential adverse event is reported through our official channels.

 

Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other potential drug-related problem.

Monitoring and surveillance involve activities such as review and evaluation of suspected adverse reaction reports, published literature, epidemiological studies and/or additional clinical trials.

Pharmaceutical Innovation Services S.L is a pharmaceutical company Holder of the Marketing Authorization of Medicines and is, therefore, obligated to maintain a Surveillance System that allows us the management of suspected adverse effects and reactions reported.

We aim to guarantee the maximum safety of the products that we commercialize.

Please report any adverse event of Pharmaceutical Innovation Services’ product at:

Telephone (24 hours): 644 13 55 02 / 655 30 63 03

E-mail: pv@

Contact Us

New Field

2 + 9 =

CONTACT

644 135 502

info@pharmaecuticalinnovation.es

C/de Luis Martínez Feduchi, 32, Atico, A, 28055 – Madrid